➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
McKesson
Boehringer Ingelheim
Johnson and Johnson
Colorcon

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ADCETRIS

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for ADCETRIS

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00848926 A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma Completed Millennium Pharmaceuticals, Inc. Phase 2 2009-02-01 This is a single-arm, open-label, multicenter, pivotal clinical trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) as a single agent in patients with relapsed or refractory Hodgkin lymphoma.
NCT00848926 A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma Completed Seattle Genetics, Inc. Phase 2 2009-02-01 This is a single-arm, open-label, multicenter, pivotal clinical trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) as a single agent in patients with relapsed or refractory Hodgkin lymphoma.
NCT00866047 A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma Completed Millennium Pharmaceuticals, Inc. Phase 2 2009-03-01 This is a single-arm, open-label, multicenter, clinical trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) as a single agent in patients with relapsed or refractory ALCL.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ADCETRIS

Condition Name

Condition Name for ADCETRIS
Intervention Trials
Hodgkin Lymphoma 14
Refractory Hodgkin Lymphoma 8
Recurrent Hodgkin Lymphoma 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for ADCETRIS
Intervention Trials
Lymphoma 61
Hodgkin Disease 45
Lymphoma, Non-Hodgkin 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for ADCETRIS

Trials by Country

Trials by Country for ADCETRIS
Location Trials
United States 357
Canada 27
Spain 14
France 13
United Kingdom 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for ADCETRIS
Location Trials
California 22
New York 21
Texas 20
Washington 17
Minnesota 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for ADCETRIS

Clinical Trial Phase

Clinical Trial Phase for ADCETRIS
Clinical Trial Phase Trials
Phase 4 3
Phase 3 4
Phase 2 37
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for ADCETRIS
Clinical Trial Phase Trials
Recruiting 33
Not yet recruiting 19
Active, not recruiting 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for ADCETRIS

Sponsor Name

Sponsor Name for ADCETRIS
Sponsor Trials
National Cancer Institute (NCI) 23
Seattle Genetics, Inc. 22
Millennium Pharmaceuticals, Inc. 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for ADCETRIS
Sponsor Trials
Other 65
Industry 44
NIH 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Boehringer Ingelheim
Harvard Business School
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.